Enhanced Efficacy of Homeophotodynamic Therapy of Rhobdomyosarcoma Cancer Cells by Using Chemo-Drug as an Adjuvant Agent
After cardiovascular diseases, the leading cause of death all around the world is cancer. Rhobdomyosarcoma (RMS) is the cancer of soft tissues and it mostly occurs in children and in adults aged between 10 and 25 years. There are several therapeutic modalities that are being used for treating cancer...
Saved in:
| Main Authors: | Afifa Tanveer, Abdul Rehman Khan, M. Rafi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-04-01
|
| Series: | Proceedings |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2504-3900/103/1/49 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biocompatible nanoparticles self-assembled by PEGylated polyphosphoesters for combination of photodynamic therapy and hypoxia-activated chemotherapy against breast cancer
by: Fengyu Wang, et al.
Published: (2024-12-01) -
PHOTODYNAMIC THERAPY FOR LUNG CANCER: MAJOR INDICATIONS
by: Yu. A. Ragulin, et al.
Published: (2016-10-01) -
Pharmaceutical and experimental-clinical aspects of photodynamic therapy combined with chemotherapy for malignant and premalignant tumors
by: Yu. S. Romanko, et al.
Published: (2025-03-01) -
Carrier-Free, Hyaluronic Acid-Modified Self-Assembled Doxorubicin, and Chlorin e6 Nanoparticles Enhance Combined Chemo- and Photodynamic Therapy in vivo
by: Lin B, et al.
Published: (2024-12-01) -
Photodynamic therapy promotes hypoxia‐activated nitrogen mustard drug release
by: Ran Wang, et al.
Published: (2024-09-01)